Navigation Links
American Board of Internal Medicine President Named to Alzheimer's Study Group
Date:11/29/2007

PHILADELPHIA, Nov. 29 /PRNewswire-USNewswire/ -- Dr. Christine Cassel, expert and author on geriatrics and medical issues related to aging, has been named a member of the Alzheimer's Study Group (ASG), a new national task force co-chaired by former Speaker of the House Newt Gingrich and former U.S. Senator Bob Kerrey.

Dr. Cassel is President and Chief Executive Officer of the American Board of Internal Medicine (http://www.abim.org), a non-profit, independent evaluation organization responsible for setting the standards and certifying the knowledge and skills of physicians who practice internal medicine and its subspecialties, including geriatric medicine.

"Nearly five million Americans are suffering from Alzheimer's and millions more loved ones are dealing with the strain, both emotional and financial, this puts on a family. As baby boomers enter their later years, we will see these numbers dramatically increase," said Dr. Cassel. "We need to act now to ensure that we improve care and develop strategies to stem the tide of this growing national health problem. I am honored to be part of this important task force and look forward to working with this group to speed the development of treatments and build supports for family members struggling to deal with the often devastating repercussions of the disease."

Author of a number of books, including Medicare Matters: What Geriatric Medicine Can Teach American Health Care (2005), Ethical Patient Care (2000), Geriatric Medicine (Fourth Edition), A Practical Guide to Aging (1997), and Approaching Death (1997), Dr. Cassel is considered one the foremost scholars on geriatric medicine. In addition to her role as President and CEO of the American Board of Internal Medicine, Dr. Cassel was previously Dean of the School of Medicine and Vice President for Medical Affairs at Oregon Health & Science University in Portland, Oregon. Among her many profe
'/>"/>

SOURCE American Board of Internal Medicine
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Aspirin Named 8th World Wonder by Majority of Americans
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire... that the Anti-infective Drugs Advisory Committee ...s voted 17 to 2 against the,approval of intraveno...t for,the treatment of patients with complicated ...uding those caused by methicillin-resistant Staphy...
(Date:11/20/2008)... LA JOLLA, Calif., Nov. 20 /PRNewswire-FirstCall/ ... DSKA), announced today that it has submitted its,...r review under a Special,Protocol Assessment (SPA...tion,(FDA). , Subject to securing an agree...ngle, prospective, double-blind, placebo-controlle...
(Date:11/20/2008)... BOSTON, Nov. 20 PAREXEL...ading global biopharmaceutical services provider, ...ma, Peru to provide regulatory consulting and clin...he Peru office, PAREXEL now has locations througho...in America, which also include Argentina, Brazil, ...
(Date:11/19/2008)... THOUSAND OAKS, Calif., Nov. 19 /PRNewswire-FirstC...he Takeda Oncology Company, a subsidiary of,Taked...y announced that,enrollment in the Phase 3 MONET1...ion with paclitaxel and carboplatin for the first-...ncer (NSCLC) has been temporarily suspended,follo...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7High Blood Pressure May Heighten Effects of Alzheimers Disease 934 1High Blood Pressure May Heighten Effects of Alzheimers Disease 934 2Transporters may help delay diabetes related retinal damage 7116 1Transporters may help delay diabetes related retinal damage 7116 2Transporters may help delay diabetes related retinal damage 7116 3Nanotechnology and the media 3A The inside story 1364 1Nanotechnology and the media 3A The inside story 1364 2Promising Data ATIR Studies Presented by NIH Investigators 1980 1Promising Data ATIR Studies Presented by NIH Investigators 1980 2
(Date:11/22/2008)... Open enrollment is now happ...over expenses not covered by Medicare, and may als... consumers are now shopping online for instant quo...ort Collins, CO (PRWEB) November 21, 2008 -- MediG... for Medicare Supplement plans . Medicare Advant...
(Date:11/21/2008)...NGE COUNTY, Calif., Nov. 21 Album ...ting firm, launches a new program offering big bra...have taken the large, expensive ad agency process ...s with a very hands-on approach," says Matt Parker... 2002, combines experience and proven brand-buildi...
(Date:11/21/2008)...s, parents and schools need to work together to st...DAY, Nov. 21 (HealthDay News) -- Behavior that was...ized as bullying. , And as mounting research sh... victim, mental-health professionals, schools, par...ew ways to combat this threatening behavior. ,...
(Date:11/21/2008)... TALLAHASSEE, Fla. -- A Florida State University C...ang has discovered an important new layer of regul... to a greater understanding of the way cancer begi... sciences at the College of Medicine, said the fin... cancer and could lead to the design of new drugs ...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3
...growth of colon polyps to half, it doubles the ris...by two significant studies published in the Aug. 3...e opinions of Bruce M. Psaty, M.D., Ph.D., and Joh...iversity of Washington were also published along w...
... only reverses the arterial dysfunction caused by ...ame arteries compared to before the meal, accordin...dings, reported in the European Journal of Applied...us on the effect food has on the body after the me...
...reas preoperative brain could effectively alter th...pear in the September issue of Radiology, states t...uage areas of the brain with functional magnetic r...e surgeons in pinpointing the brain tumors more ef...
...as challenged the view of The Sterling Council, of...alarm service, which the// Scottish public service...minced words that the ruling is a target at the we...ruly a mockery of the free care provided for the e...
Other Medicine News:Health News:Celebrex- pros and cons 2Health News:A Serving of Exercise After That Saturated Fat 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 2Health News:fMRI Prior to surgery Could Help In Outcome Of Tumor Surgery 3
Bandeau Bra
Bras and Breast Support
Compression Bra
Constructed from soft Shur-grip foam and velcro closure for easy application and - reapplication
Medicine Products: